SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT
16 references·8 citing·44 second hop
Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT (2017)Short term changes in the proteome of hum…New Insights in Anorexia Nervosa (2016)New Insights in Anorexia Nerv…Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities (2015)Psychedelics and Immunomodula…Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans (2015)Long-term use of psychedelic …Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report (2015)Antidepressant effects of a s…Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression (2015)Antidepressant Effects of a S…Effects of Schedule I drug laws on neuroscience research and treatment innovation (2013)Effects of Schedule I drug la…Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada (2013)Ayahuasca-Assisted Therapy fo…Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study (2012)Personality, Psychopathology,…Animal Models of Serotonergic Psychedelics (2012)Animal Models of Serotonergic…A critical review of reports of endogenous psychedelic N, N‐dimethyltryptamines in humans: 1955–2010 (2012)A critical review of reports …Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges (2011)Ayahuasca and the process of …The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (2010)The neurobiology of psychedel…Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions (2010)Psychedelic 5-Methoxy-N,N-Dim…Assessment of addiction severity among ritual users of ayahuasca (2010)Assessment of addiction sever…Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Psilocybin can occasion mysti…Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges (2004)Clinical investigations of th…The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) (2022)The clinical pharmacology and…Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity (2022)Biochemical Mechanisms Underl…From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders (2021)From psychiatry to neurology:…A narrative synthesis of research with 5-MeO-DMT (2021)A narrative synthesis of rese…Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans (2020)Psychedelic Treatment for Tra…Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers (2020)Low Doses of LSD Acutely Incr…Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment (2019)Prospective examination of sy…Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process (2018)Hypothesis: The Psychedelic A…A Psychobiological Model of Temperament and Character (1993)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (2012)Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities (2015)Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking (2016)Clinical applications of hallucinogens: A review. (2016)"A Controlled Study" (1966)Hallucinogens (2004)Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function (2018)Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders (2020)Psychedelics and Psychedelic-Assisted Psychotherapy (2020)Power failure: why small sample size undermines the reliability of neuroscience (2013)LSD enhances suggestibility in healthy volunteers (2014)Blinding and expectancy confounds in psychedelic randomized controlled trials (2021)Adverse effects of psychedelics: From anecdotes and misinformation to systematic science (2022)A compendium of neuropsychological tests: administration, norms, and commentary (1991)A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (1993)Psychedelics not linked to mental health problems or suicidal behavior: A population study (2015)Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years (2016)Towards an understanding of psychedelic-induced neuroplasticity (2022)Stages of change and decisional balance for 12 problem behaviors. (1994)Multidimensional Assessment of Emotion Regulation and Dysregulation: Development, Factor Structure, and Initial Validation of the Difficulties in Emotion Regulation Scale (2003)LSD‐induced entropic brain activity predicts subsequent personality change (2016)Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics (2003)The Pharmacology of Lysergic Acid Diethylamide: A Review (2008)Classic hallucinogens in the treatment of addictions (2015)Ayahuasca: Pharmacology, neuroscience and therapeutic potential (2016)"Mysticism and Philosophy" (1960)Psychedelics (2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Mysticism and Philosophy (2024)A RATING SCALE FOR DEPRESSION (1960)The Brief Psychiatric Rating Scale (1962)A New Depression Scale Designed to be Sensitive to Change (1979)Psychedelics as Medicines: An Emerging New Paradigm (2016)Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies (2020)Hallucinogens and shamanism (1973)Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)Amazonia 1492: Pristine Forest or Cultural Parkland? (2003)The hallucinogenic world of tryptamines: an updated review (2015)Reviewing the Potential of Psychedelics for the Treatment of PTSD (2020)Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases (2014)Psychiatry & the psychedelic drugs. Past, present & future (2017)
this work references cited by second hop

References

  • 2006Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance1,682 cited
  • 2010The neurobiology of psychedelic drugs: implications for the treatment of mood disorders720 cited
  • 2015Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report485 cited
  • 2015Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression465 cited
  • 2013Effects of Schedule I drug laws on neuroscience research and treatment innovation338 cited
  • 2013Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada330 cited
  • 2004Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges321 cited
  • 2012Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study313 cited
  • 2010Assessment of addiction severity among ritual users of ayahuasca227 cited
  • 2015Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans218 cited
  • 2016New Insights in Anorexia Nervosa193 cited
  • 2010Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions170 cited
  • 2012Animal Models of Serotonergic Psychedelics155 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2015Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities150 cited
  • 2011Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges146 cited
  • 2012A critical review of reports of endogenous psychedelic N, N‐dimethyltryptamines in humans: 1955–2010141 cited
  • Cited by

    • 2022Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity131 cited
    • 2020Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers130 cited
    • 2019Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment117 cited
    • 2022The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)112 cited
    • 2018Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process91 cited
    • 2021A narrative synthesis of research with 5-MeO-DMT86 cited
    • 2020Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans84 cited
    • 2021From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders81 cited